Meeting ReportOncology: Clinical Therapy and Diagnosis
Peptide Receptor Radionuclide Therapy (PRRT) in Patients with Progressive Grade 3 Neuroendocrine Neoplasms (NEN)
Jingjing Zhang, Harshad Kulkarni, AVIRAL SINGH, Karin Niepsch, Dirk Mueller and Richard Baum
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 560;
Jingjing Zhang
4THERANOSTICS Center for Molecular Radiotherapy & Precision Oncology Zentralklinik Bad Berka Bad Berka Germany
Harshad Kulkarni
3Zentralklinik Bad Berka Bad Berka, Thuringia Germany
AVIRAL SINGH
5Zentralklinik Bad Berka GmbH BAD BERKA Germany
Karin Niepsch
1Zentralklinik Bad Berka Bad Berka Germany
2Zentralklinik Bad Berka Bad Berka Germany
Dirk Mueller
6Radiopharmacy Zentralklinik Bad Berka GmbH Bad Berka Germany
Richard Baum
1Zentralklinik Bad Berka Bad Berka Germany
2Zentralklinik Bad Berka Bad Berka Germany
In this issue
Journal of Nuclear Medicine
Vol. 60, Issue supplement 1
May 1, 2019
Peptide Receptor Radionuclide Therapy (PRRT) in Patients with Progressive Grade 3 Neuroendocrine Neoplasms (NEN)
Jingjing Zhang, Harshad Kulkarni, AVIRAL SINGH, Karin Niepsch, Dirk Mueller, Richard Baum
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 560;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.